The FDA posted to its set a warning letter previously sent to Owens & Minor, Inc. dba American Contract Systems, following an inspection that was conducted on August 5 through 14, 2024.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMI:
- Owens & Minor’s Rotech Acquisition: Navigating Integration Challenges and Risks
- Owens & Minor Updates Executive Compensation Plan
- Owens & Minor price target lowered to $14 from $19 at Baird
- Owens & Minor price target lowered to $18.50 from $21 at Citi
- Owens & Minor price target lowered to $14 from $18 at Barclays